| 19th Aug 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 19th Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 18th Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 15th Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 14th Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 13th Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 12th Aug 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 12th Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 11th Aug 2025 7:00 am |
RNS |
FDA to review gonorrhea indication for gepotidacin |
| 11th Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 8th Aug 2025 7:00 am |
RNS |
CureVac/BioNTech mRNA patent litigation settlement |
| 8th Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 7th Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 6th Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 5th Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 4th Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 1st Aug 2025 3:00 pm |
RNS |
Total Voting Rights |
| 1st Aug 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 31st Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 30th Jul 2025 7:05 am |
RNS |
Transaction in Own Shares |
| 30th Jul 2025 7:00 am |
RNS |
2nd Quarter Results |
| 29th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 28th Jul 2025 7:00 am |
RNS |
GSK enters Hengrui Pharma collaboration agreements |
| 28th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 25th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 24th Jul 2025 5:00 pm |
RNS |
Blenrep approved in the EU for multiple myeloma |
| 24th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 23rd Jul 2025 5:00 pm |
RNS |
US FDA review extended for Blenrep |
| 23rd Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 22nd Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 21st Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 18th Jul 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 18th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 18th Jul 2025 7:00 am |
RNS |
Blenrep US ODAC outcome |
| 17th Jul 2025 7:00 am |
RNS |
GSK’s Shingrix Fully Liquid FDA approval |
| 17th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 15th Jul 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 15th Jul 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 14th Jul 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
